Free Content Possible role of the innate immunity in temporal lobe epilepsy

Authors: van Gassen, Koen L.I.1; de Wit, Marina1; Koerkamp, Marian J.A. Groot2; Rensen, Marije G.A.1; van Rijen, Peter C.1; Holstege, Frank C.P.2; Lindhout, Dick3; de Graan, Pierre N.E.1

Source: Epilepsia, Volume 49, Number 6, June 2008 , pp. 1055-1065(11)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

You have access to the full text article on a website external to ingentaconnect.

Please click here to view this article on Wiley Online Library.

You may be required to register and activate access on Wiley Online Library before you can obtain the full text. If you have any queries please visit Wiley Online Library

Abstract:

Summary

Purpose: Temporal lobe epilepsy (TLE) is a multifactorial disease often involving the hippocampus. So far the etiology of the disease has remained elusive. In some pharmacoresistant TLE patients the hippocampus is surgically resected as treatment. To investigate the involvement of the immune system in human TLE, we performed large-scale gene expression profiling on this human hippocampal tissue.

Methods: Microarray analysis was performed on hippocampal specimen from TLE patients with and without hippocampal sclerosis and from autopsy controls (n = 4 per group). We used a common reference pool design to perform an unbiased three-way comparison between the two patient groups and the autopsy controls. Differentially expressed genes were statistically analyzed for significant overrepresentation of gene ontology (GO) classes.

Results: Three-way analysis identified 618 differentially expressed genes. GO analysis identified immunity and defense genes as most affected in TLE. Particularly, the chemokines CCL3 and CCL4 were highly (>10-fold) upregulated. Other highly affected gene classes include neuropeptides, chaperonins (protein protection), and the ubiquitin/proteasome system (protein degradation).

Discussion: The strong upregulation of CCL3 and CCL4 implicates these chemokines in the etiology and pathogenesis of TLE. These chemokines, which are mainly expressed by glia, may directly or indirectly affect neuronal excitability. Genes and gene clusters identified here may provide targets for developing new TLE therapies and candidates for genetic research.

Keywords: Chemokines; Temporal lobe epilepsy; Microarrays; Human; Hippocampus; Immune system

Document Type: Research article

DOI: http://dx.doi.org/10.1111/j.1528-1167.2007.01470.x

Affiliations: 1: Rudolf Magnus Institute of Neuroscience, Department of Neuroscience and Pharmacology, University Medical Center Utrecht, Utrecht, The Netherlands 2: Department of Physiological Chemistry, University Medical Center Utrecht, Utrecht, The Netherlands 3: DBG-Department of Medical Genetics, University Medical Center Utrecht, Utrecht, The Netherlands

Publication date: 2008-06-01

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page